These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29865876)

  • 41. SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2018.
    Clothier HJ; Lawrie J; Lewis G; Russell M; Crawford NW; Buttery JP
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32536336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Revised World Health Organization (WHO)'s causality assessment of adverse events following immunization-a critique.
    Puliyel J; Naik P
    F1000Res; 2018; 7():243. PubMed ID: 30026925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surveillance of adverse events following immunisation in Australia annual report, 2017.
    Dey A; Wang H; Quinn H; Hiam R; Wood N; Beard F; Macartney K
    Commun Dis Intell (2018); 2019 Jul; 43():. PubMed ID: 31315166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Active surveillance of adverse events following immunization (AEFI): a prospective 3-year vaccine safety study.
    Sebastian J; Gurumurthy P; Ravi MD; Ramesh M
    Ther Adv Vaccines Immunother; 2019; 7():2515135519889000. PubMed ID: 31799496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adverse events following HPV vaccination, Alberta 2006-2014.
    Liu XC; Bell CA; Simmonds KA; Svenson LW; Russell ML
    Vaccine; 2016 Apr; 34(15):1800-5. PubMed ID: 26921782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China.
    Wang C; Huang N; Lu QB; Black S; Liang X; Cui F
    Front Immunol; 2022; 13():956473. PubMed ID: 36248783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Temporal association between serious bleeding and immunization: vitamin K deficiency as main causative factor.
    Susanah S; Fadlyana E; Dhamayanti M; Tarigan R; Ariyanto EF; Pamela Y; Ismoetoto YIB; Sri RV; Hasna M; Rusmil K
    BMC Pediatr; 2020 Feb; 20(1):82. PubMed ID: 32085705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surveillance of adverse events following varicella vaccine immunization in Jiangsu province, China from 2017 to 2023.
    Zhang L; Fu Y; Wang W; Liu Y; Hu R; Wang Z; Sun X
    BMC Infect Dis; 2024 Sep; 24(1):983. PubMed ID: 39285384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Annual report: surveillance of adverse events following immunisation in Australia, 2007.
    Lawrence G; Gold MS; Hill R; Deeks S; Glasswell A; McIntyre PB
    Commun Dis Intell Q Rep; 2008 Dec; 32(4):371-87. PubMed ID: 19374268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse events following COVID-19 vaccination: first 90 days of experience from a tertiary care teaching hospital in South India.
    Basavaraja CK; Sebastian J; Ravi MD; John SB
    Ther Adv Vaccines Immunother; 2021; 9():25151355211055833. PubMed ID: 34841193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015-2018.
    Hu R; Peng S; Liu Y; Tang F; Wang Z; Zhang L; Gao J; Guo H
    BMC Public Health; 2021 Jul; 21(1):1338. PubMed ID: 34229643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imprecision in vaccine adverse event reporting and a methodological analysis of reporting systems to improve pharmacovigilance and public health.
    Inokuma Y; Kneller R
    Eur J Clin Pharmacol; 2023 Jul; 79(7):989-1002. PubMed ID: 37249640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Causality assessment of adverse events following immunization: the problem of multifactorial pathology.
    Bellavite P
    F1000Res; 2020; 9():170. PubMed ID: 32269767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the adverse events following immunization surveillance system in Guruve district, Mashonaland Central 2017.
    Constantine M; Cremance T; Juru TP; Gerald S; Notion GT; Peter N; Mufuta T
    Pan Afr Med J; 2018; 31():202. PubMed ID: 31452827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia.
    Baxter CM; Clothier HJ; Perrett KP
    Hum Vaccin Immunother; 2018; 14(8):2088-2092. PubMed ID: 29624467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccine-related adverse events in Cuban children, 1999-2008.
    Galindo BM; Concepción D; Galindo MA; Pérez A; Saiz J
    MEDICC Rev; 2012 Jan; 14(1):38-43. PubMed ID: 22334111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
    Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
    Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.